A detailed history of Valley National Advisers Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Valley National Advisers Inc holds 7,639 shares of NVO stock, worth $667,419. This represents 0.16% of its overall portfolio holdings.

Number of Shares
7,639
Previous 11,896 35.79%
Holding current value
$667,419
Previous $1.7 Million 46.47%
% of portfolio
0.16%
Previous 0.25%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $506,880 - $619,052
-4,257 Reduced 35.79%
7,639 $909,000
Q2 2024

Jul 18, 2024

SELL
$122.71 - $146.91 $199,158 - $238,434
-1,623 Reduced 12.01%
11,896 $1.7 Million
Q1 2024

Apr 19, 2024

SELL
$102.11 - $135.92 $472,667 - $629,173
-4,629 Reduced 25.51%
13,519 $1.74 Million
Q4 2023

Jan 25, 2024

SELL
$87.78 - $105.45 $94,626 - $113,675
-1,078 Reduced 5.61%
18,148 $1.88 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $839,921 - $1.84 Million
9,236 Added 92.45%
19,226 $1.75 Million
Q2 2023

Jul 31, 2023

SELL
$155.98 - $172.65 $111,681 - $123,617
-716 Reduced 6.69%
9,990 $1.62 Million
Q1 2023

Apr 26, 2023

SELL
$132.34 - $159.14 $102,298 - $123,015
-773 Reduced 6.73%
10,706 $1.83 Million
Q4 2022

Jan 12, 2023

SELL
$102.55 - $135.33 $2.22 Million - $2.93 Million
-21,637 Reduced 65.34%
11,479 $1.52 Million
Q3 2022

Nov 08, 2022

SELL
$95.28 - $116.93 $6,002 - $7,366
-63 Reduced 0.19%
33,116 $3.53 Million
Q2 2022

Jul 15, 2022

SELL
$103.24 - $121.81 $18,686 - $22,047
-181 Reduced 0.54%
33,179 $3.65 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $14,286 - $17,444
-149 Reduced 0.44%
33,360 $3.74 Million
Q3 2021

Nov 10, 2021

SELL
$84.42 - $106.62 $33,599 - $42,434
-398 Reduced 1.17%
33,509 $3.22 Million
Q2 2021

Aug 02, 2021

BUY
$67.66 - $84.76 $7,983 - $10,001
118 Added 0.35%
33,907 $2.84 Million
Q1 2021

May 07, 2021

SELL
$67.06 - $75.82 $10,595 - $11,979
-158 Reduced 0.47%
33,789 $2.28 Million
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $8,752 - $10,110
-137 Reduced 0.4%
33,947 $2.37 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $12,419 - $13,692
-195 Reduced 0.57%
34,084 $2.37 Million
Q2 2020

Aug 10, 2020

SELL
$58.54 - $67.94 $109,879 - $127,523
-1,877 Reduced 5.19%
34,279 $2.25 Million
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $106,685 - $139,730
-2,157 Reduced 5.63%
36,156 $2.18 Million
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $74,790 - $87,390
1,500 Added 4.07%
38,313 $2.22 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $539,626 - $606,483
11,351 Added 44.58%
36,813 $1.9 Million
Q2 2019

Aug 08, 2019

BUY
$46.79 - $52.47 $31,442 - $35,259
672 Added 2.71%
25,462 $1.3 Million
Q1 2019

Apr 26, 2019

BUY
$46.36 - $52.63 $674,306 - $765,503
14,545 Added 141.97%
24,790 $1.3 Million
Q4 2018

Feb 25, 2019

BUY
$41.54 - $47.25 $387,318 - $440,559
9,324 Added 1012.38%
10,245 $472,000
Q1 2018

Apr 19, 2018

SELL
$48.49 - $58.14 $5,042 - $6,046
-104 Reduced 10.15%
921 $45,000
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $42,178 - $50,450
1,025
1,025 $49,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.